Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic HCV for Use in the Peri-Operative Liver Transplantation Setting
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic HCV for Use in the Peri-Operative Liver Transplantation Setting
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic HCV for Use in the Peri-Operative Liver Transplantation Setting
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New Orleans, LA
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic HCV for Use in the Peri-Operative Liver Transplantation Setting
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic HCV for Use in the Peri-Operative Liver Transplantation Setting
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic HCV for Use in the Peri-Operative Liver Transplantation Setting
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic HCV for Use in the Peri-Operative Liver Transplantation Setting
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New York, NY
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic HCV for Use in the Peri-Operative Liver Transplantation Setting
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic HCV for Use in the Peri-Operative Liver Transplantation Setting
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic HCV for Use in the Peri-Operative Liver Transplantation Setting
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Alabama
mi
from
Birmingham, AL
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated:  12/31/1969
Arkansas Children's Hospital
mi
from
Little Rock, AR
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated: 12/31/1969
Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated:  12/31/1969
Nemours Alfred Dupont Hospital for Children
mi
from
Wilmington, DE
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated: 12/31/1969
Nemours Alfred Dupont Hospital for Children
mi
from
Wilmington, DE
Click here to add this to my saved trials
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated:  12/31/1969
University of Florida Children's Hospital
mi
from
Gainesville, FL
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated: 12/31/1969
University of Florida Children's Hospital
mi
from
Gainesville, FL
Click here to add this to my saved trials
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated:  12/31/1969
Norton Children's Hospital
mi
from
Louisville, KY
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated: 12/31/1969
Norton Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Childrens Center
mi
from
Baltimore, MD
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Childrens Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Michigan
mi
from
Detroit, MI
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Michigan
mi
from
Detroit, MI
Click here to add this to my saved trials
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated:  12/31/1969
St. Louis Children's Hospital
mi
from
Saint Louis, MO
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated: 12/31/1969
St. Louis Children's Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated:  12/31/1969
Akron Children's Hospital
mi
from
Akron, OH
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated: 12/31/1969
Akron Children's Hospital
mi
from
Akron, OH
Click here to add this to my saved trials
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated:  12/31/1969
Doernbecher Children's Hospital
mi
from
Portland, OR
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated: 12/31/1969
Doernbecher Children's Hospital
mi
from
Portland, OR
Click here to add this to my saved trials
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina Children's Hospital
mi
from
Charleston, SC
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina Children's Hospital
mi
from
Charleston, SC
Click here to add this to my saved trials
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated:  12/31/1969
Texas Children's Hospital
mi
from
Houston, TX
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated: 12/31/1969
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated:  12/31/1969
Children's Hospital at Montefiore
mi
from
Bronx, NY
Community Central Line Infection Prevention Trial
Community Central Line Infection Prevention Trial
Status: Enrolling
Updated: 12/31/1969
Children's Hospital at Montefiore
mi
from
Bronx, NY
Click here to add this to my saved trials
Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed
A Randomized, Open-label Study to Evaluate the Immunogenicity of Anthrax Vaccine Adsorbed Alone or Concomitantly With Raxibacumab (GSK3068483)
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Overland Park, KA
Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed
A Randomized, Open-label Study to Evaluate the Immunogenicity of Anthrax Vaccine Adsorbed Alone or Concomitantly With Raxibacumab (GSK3068483)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed
A Randomized, Open-label Study to Evaluate the Immunogenicity of Anthrax Vaccine Adsorbed Alone or Concomitantly With Raxibacumab (GSK3068483)
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Edgewater, FL
Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed
A Randomized, Open-label Study to Evaluate the Immunogenicity of Anthrax Vaccine Adsorbed Alone or Concomitantly With Raxibacumab (GSK3068483)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Edgewater, FL
Click here to add this to my saved trials
Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed
A Randomized, Open-label Study to Evaluate the Immunogenicity of Anthrax Vaccine Adsorbed Alone or Concomitantly With Raxibacumab (GSK3068483)
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Knoxville, TN
Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed
A Randomized, Open-label Study to Evaluate the Immunogenicity of Anthrax Vaccine Adsorbed Alone or Concomitantly With Raxibacumab (GSK3068483)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children
Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children
Status: Enrolling
Updated:  12/31/1969
Children's Mercy Hospital - Kansas City
mi
from
Kansas City, MO
Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children
Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospital - Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
Short-course Methenamine Hippurate for Prevention of Post-operative UTI
The Efficacy and Cost-effectiveness of a 24-hour Course of metheNamine Hippurate for Preventing Post-Operative Urinary Tract Infection
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Short-course Methenamine Hippurate for Prevention of Post-operative UTI
The Efficacy and Cost-effectiveness of a 24-hour Course of metheNamine Hippurate for Preventing Post-Operative Urinary Tract Infection
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Short-course Methenamine Hippurate for Prevention of Post-operative UTI
The Efficacy and Cost-effectiveness of a 24-hour Course of metheNamine Hippurate for Preventing Post-Operative Urinary Tract Infection
Status: Enrolling
Updated:  12/31/1969
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
Short-course Methenamine Hippurate for Prevention of Post-operative UTI
The Efficacy and Cost-effectiveness of a 24-hour Course of metheNamine Hippurate for Preventing Post-Operative Urinary Tract Infection
Status: Enrolling
Updated: 12/31/1969
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Short-course Methenamine Hippurate for Prevention of Post-operative UTI
The Efficacy and Cost-effectiveness of a 24-hour Course of metheNamine Hippurate for Preventing Post-Operative Urinary Tract Infection
Status: Enrolling
Updated:  12/31/1969
Pennsylvania Hospital
mi
from
Philadelphia, PA
Short-course Methenamine Hippurate for Prevention of Post-operative UTI
The Efficacy and Cost-effectiveness of a 24-hour Course of metheNamine Hippurate for Preventing Post-Operative Urinary Tract Infection
Status: Enrolling
Updated: 12/31/1969
Pennsylvania Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Short-course Methenamine Hippurate for Prevention of Post-operative UTI
The Efficacy and Cost-effectiveness of a 24-hour Course of metheNamine Hippurate for Preventing Post-Operative Urinary Tract Infection
Status: Enrolling
Updated:  12/31/1969
Chestnut Hill Hospital
mi
from
Philadelphia, PA
Short-course Methenamine Hippurate for Prevention of Post-operative UTI
The Efficacy and Cost-effectiveness of a 24-hour Course of metheNamine Hippurate for Preventing Post-Operative Urinary Tract Infection
Status: Enrolling
Updated: 12/31/1969
Chestnut Hill Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigational site
mi
from
Birmingham, AL
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigational site
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigational site
mi
from
Flagstaff, AZ
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigational site
mi
from
Flagstaff, AZ
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigational site
mi
from
Bakersfield, CA
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigational site
mi
from
Bakersfield, CA
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigational site
mi
from
Los Angeles, CA
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigational site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigational site
mi
from
Orange, CA
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigational site
mi
from
Orange, CA
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigational Site
mi
from
San Jose, CA
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigational Site
mi
from
San Jose, CA
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigational site
mi
from
Stockton, CA
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigational site
mi
from
Stockton, CA
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigational site
mi
from
Centennial, CO
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigational site
mi
from
Centennial, CO
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigational site
mi
from
Denver, CO
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigational site
mi
from
Denver, CO
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigational site
mi
from
Hialeah, FL
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigational site
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigational site
mi
from
New Port Richey, FL
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigational site
mi
from
New Port Richey, FL
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigational site
mi
from
Oviedo, FL
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigational site
mi
from
Oviedo, FL
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigation site
mi
from
Palmetto Bay, FL
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigation site
mi
from
Palmetto Bay, FL
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigational site
mi
from
Tallahassee, FL
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigational site
mi
from
Tallahassee, FL
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigational site
mi
from
Twin Falls, ID
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigational site
mi
from
Twin Falls, ID
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigational site
mi
from
Baltimore, MD
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigational site
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigational site
mi
from
Bellevue, NE
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigational site
mi
from
Bellevue, NE
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota investigational site
mi
from
Las Vegas, NV
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota investigational site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigational site
mi
from
Albuquerque, NM
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigational site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigational site
mi
from
Rockville Centre, NY
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigational site
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated:  12/31/1969
Biota Investigational site
mi
from
Raleigh, NC
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Status: Enrolling
Updated: 12/31/1969
Biota Investigational site
mi
from
Raleigh, NC
Click here to add this to my saved trials